Clinical Trial Update: Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted Prostatectomy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating recovery from neuromuscular block using different sugammadex doses in elderly patients undergoing robot-assisted prostatectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Blockade
• Prostate Cancer

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Prostate Cancer, Neuromuscular Blockade | Phase 3 | Status: COMPLETED